FDA approved a pill that would change the way scientists treat cancer … for good. The pill was called Gleevec; it was ...

When the Food and Drug Administration approved Gleevec to treat a form of leukemia in 2001, it ushered in a new era in cancer ...

Gleevec is a revolutionary drug that has helped transform some blood cancers into chronic illnesses rather than death sentences. Around since 2001, new uses have been found for the drug every few ...

Gleevec contains the drug imatinib, which belongs to a class of drugs called tyrosine kinase inhibitors (TKIs). Medications in the TKI drug class are targeted therapies. They affect specific proteins ...

Gleevec (imatinib) is a brand-name oral tablet prescribed for some types of blood cancer in adults and some children. It’s also used in adults to treat some types of gastrointestinal cancer and skin ...

Nonadherence to Gleevec in GIST patients is common, with cognitive functioning, TDM, and social support as key indicators. A machine learning model using 64 covariates identified 19 significant ...

KIT-exon-11 mutations in GISTs correlate with higher partial response rates and improved surgical outcomes with neoadjuvant Gleevec. Non-KIT exon 11 mutations and wild-type KIT/PDGFRA GISTs show less ...

Gleevec (imatinib) is a prescription oral tablet used to treat certain types of cancer or blood disorders. It can interact with some supplements and other medications, such as certain seizure drugs ...

The U.S. Food and Drug Administration today approved Gleevec (imatinib mesylate) for a new indication - keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal ...

If you have a certain type of cancer, your doctor might suggest Gleevec (imatinib) as a treatment option for you. Along with other questions you may have about the drug, you could be wondering about ...